Major depresif bozukluk hastalarında elektrokonvülzif terapi (EKT) süre ve sayılarının, klinik izleme ve tedaviye etkileri Amaç: Major depresif bozukluk hastalarında EKT sürelerinin ve sayısının klinik gidiş ve tedavi üzerine olan etkilerini araş-tırmaktır. Yöntem: Çalışma Erenköy Ruh ve Sinir Hastalıkları Eğitim ve Araştırma Hastanesi (ERSHEAH) psikiyatri kliniğine major depresif bozukluk tanısı ile yatarak tedavi gören, EKT endikasyonu almış toplam 50 hasta ile yapılmıştır. Hastalara EKT öncesi ve EKT'nin 1. ve 2. haftalarında Hamilton Depresyon Ölçeği (HDÖ), EKT yapıldıktan sonraki günlerde Klinik Global İzlem Ölçeği (KGİÖ) uygulanmış, EKT'lerin toplam nöbet süreleri değer-lendirilmiştir. Ayrıca hastaların sosyodemografik özelliklerini ve daha önceki EKT öykülerini, şuan ki EKT endikasyonlarını tanımlayan bir veri formu uygulanmıştır. Bulgular: Hastalar EKT endikasyonuna göre; Tedaviye direnç (+): Grup I, İntihar düşüncesi (+): Grup II olarak değerlendirilmiş ve gruplar arasında sosyodemografik özellikler ile toplam EKT sayısı, EKT süresi, EKT öncesi ve EKT sonrası 1. ve 2. haftada HDÖ puanları arasında istatistiksel olarak anlamlı bir fark saptanmamıştır (p>0.05). Her EKT sonrası bakılan KGİÖ ölçek puanlarında istatistiksel olarak anlamlı oranda azalma gözlenir-ken (p<0.001), EKT sonrası uygulanan KGİÖ puanlarında azalma gözlenen hasta sayıları artmıştır. EKT öyküsü olan hastaların %45.5'inde, EKT öyküsü olmayan hastaların ise %82.9'sında remisyon gözlenmiştir (p<0.05). Tartışma: Çalışmamızın verilerine göre; tedavi direnci ve intihar düşüncesi olan depresif bozukluk hastalarında EKT tedavisinin yeterli sayı ve sürede yapıldığında, depresyon ve klinik iyileşme düzeylerine etki eden bir tedavi yöntemi olduğunu söyleyebiliriz. EKT'den daha önce fayda görmüş olan hastaların, olmayanlara göre remisyon oranların daha az olması hastalığın kronik sürece girmiş olabileceğini veya daha önceki EKT'lerin tedavi duyarlılığını azaltmış olabileceği ihtimalini düşündürmüştür. Impacts of the duration and number of electroconvulsive therapy (ECT) sessions on clinical course and treatment of the patients with major depressive disorder Objective: The aim of this study is to investigate impacts of the duration and number of electroconvulsive therapies on clinical course and treatment of the patients with major depressive disorder. Method: This study included 50 patients, who applied to psychiatry clinic of Erenkoy Mental Health and Neurology Training & Research Hospital for inpatient treatment due to the diagnosis of major depressive disorder and who displayed electroconvulsive therapy (ECT) indication. The patients were subjected to Hamilton Rating Scale for Depression (HRSD) for pre-ECT period and for 1 st and 2 nd weeks of ECT, and to Clinical Global Impression Scale (CGIS) for the period following application of ECT. Total durations of ECT convulsions were assessed. Furthermore, a data form identifying sociodemographic properties, previous ECT history and current ECT indications of the patients was filled in. Results: The patients were classified by ECT indications as Resistance to Treatment (+): Group I, Suicide Ideation (+): Group II; and no statistically significant difference was observed among groups in terms of sociodemographic properties, total number of ECT sessions, duration of ECT, and HRSD scores for pre-ECT period and for 1 st and 2 nd weeks of ECT (p>0.05). CGIS scores checked after each ECT statistically significantly decreased (p<0.001), while the number of patients with decreased CGIS scores obtained after application of ECT increased. 45.5% of the patients with ECT history and 82.9% of the patients without any ECT history were determined to have got into remission (p<0.05). Conclusion: According to the data evaluated in this study, we can safely argue that if the patients with major depressive disorder displaying resistance to treatment, refusal to eat and drink and suicide ideation were allowed to have sufficient number of ECT sessions with sufficient duration, ECT would work as an effective treatment method affecting depression and clinical improvement levels. The fact that the patients with positive ECT history have lower rate of remission as compared to the patients without ECT history made the authors consider the possibility that the disease may have crossed into chronic stage or former ECT sessions may have decreased the susceptibility to treatment.
Impacts of the Duration and Number of Electroconvulsive Therapy (ECT) Sessions on Clinical

INTRODUCTION
Electroconvulsive therapy (ECT) is an effective treatment method to manage certain psychiatric disorders, and it does not have obvious side effects (1) . Efficiency of ECT is associated with the length of seizure and stimulus dose above seizure threshold (2) . An effective seizure is regarded as the one, which takes 25 seconds as a minimum.
Although the length of seizure, when taken as the sole parameter, is not sufficient to evaluate effectiveness, it is considered that any convulsion shorter than 15 seconds and any seizure activity shorter than 25 seconds, as ECT's effectiveness in major depressive disorder is unknown. But, in a study dedicated, convulsive threshold increased with age, ethnicity, diagnosis other than depression, and female sex, and decreased with right unilateral electrode placement, low frequency and brief pulse width. ECT efficiency appears to be achieved by lower frequency and briefer pulse duration stimulation (7) . In this study, we aimed to examine the impacts of the duration and number of electroconvulsive therapy (ECT) sessions on clinical course and treatment of the patients with major depressive disorder, who also have current suicidal ideation and resistance to treatment.
METHODS
Procedure
This study with its prospective nature was conducted with 50 patients, who were treated and followed up at inpatient clinics between January 2015 and June 2015, informed about and accepted to take part in the study, diagnosed with major depressive disorder, displayed ECT indication and received treatment. The study was performed after approval from Ethics Committee was obtained. The patients with whom no remission was ensured in spite of the use of two different groups of antidepressants at sufficient doses and for sufficient durations were described as treatment-resistant; Group I.
The patients who had current suicidal ideation or suicide attempt with ongoing suicidal ideation were described as suicidal ideation group; Group II.
Electrocardiogram (ECG), posteroanterior chest X-ray (CXR), blood biochemistry, and complete blood count examinations were done to all patients prior to ECT application. After consent of patient for ECT was obtained in the light of the tests and examinations carried out by an internist and anesthesiologist, the ECT procedure was initiated. Informed consent of the patients and/or their relatives was obtained before application of therapy. In the ordinary course of operation at our clinic, ECT with shortpulse width with the brand name Thymatron System IV is used. Bilateral-bitemporal ECT was applied to the patients.
Frequency of ECT sessions was around 2-3 times a week. It was preferred to apply 7-10 ECT sessions on average to each patient, however this number may be increased or decreased depending on the clinical response of any individual patient.
All ECT sessions were applied at ECT unit of our hospital accompanied by an anesthesiologist. The patients were fasted at least 12 hours before the application and their regular psychotropic drugs were discontinued as fully as possible. Prior to ECT application, vascular line was established on patients' back of hand; 0.5 mg atropine was administered intravenously so as to reduce salivation and to prevent increased hearth beat, which was followed by administration of propofol (1 mg/kg) to induce anesthesia and succinylcholine (0.5 mg/kg) as neuromuscular blocker.
Normally, all patients taken to application room were subjected to measurement of heart rate and systolic, diastolic and mean arterial blood pressure, as well as peripheric oxygen saturation and EEG monitoring. for DSM-IV Axis I disorders. Turkish version's reliability and validity study of has been performed (10).
Hamilton Rating Scale for Depression (HRSD):
HRSD was first developed originally by Max Hamilton in 1960 and it is the most commonly used rating scale for depression (11) . Arithmetical addition of the scores obtained from each item represents the total score. A score of 0-7 is considered to be normal; i.e. non-depressive. The meaning of what each score represents is as follows:
1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; 7=among the most extremely ill patients. CGIS-2 is also a 7-point scale that requires the clinician to evaluate how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention from 1 to 7. Results are interpreted as follows: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6= much worse; 7=very much worse.
Informed consent form: It is designed as a paper, which indicates the acceptance of the patient to take part in the study, and provides information about the study.
Statistical Analysis
Statistical analysis was performed using Statistical 
RESULTS
The study included 50 patients in total, who displayed The one-way analysis of variance was performed and was compared the total number of ECT sessions applied to patient groups, pre-ECT and post-ECT HRSD scores, and total length of ECT. As no significant inter-group difference was found, In consequence of the comparative assessment made among patient groups, it was observed that CGIS scores checked after each ECT decreased consecutively (Table 3) .
There was a consecutive difference between each post-ECT CGIS score at a statistically significant level (p<0.001).
On the other hand the number of patients who had reduced CGIS scores consecutively increased after each ECT ( Table 4) .
As a result of the comparative evaluation made among patient groups, it was found that there was no significant difference between the number and percentage of patients after ECT and the number of patients whose HRSD scores remained below 7 and therefore got into remission increased dramatically (p>0.05) ( Table 5) .
Additionally, the distribution of getting into remission status by the end of 2 nd week between the patients with ECT history and those without any ECT history was as below;
45.5% of the patients with ECT history and 82.9% of the patients without any ECT history were determined to have got into remission (p<0.05) ( Table 6 ). Rate of response to treatment as per 7 (16) has an important role in potential antidepressant activity (15) (16) (17) . After all, one of the psychiatric disorders where ECT has an effective use is major depressive disorder. Therefore, in the scope of our study, ECT was applied to the patients who were diagnosed with major depressive disorder and who were considered to have resistance to treatment and current suicidal ideation. In our study, no statistically significant differences were found among patient groups in terms of total number of ECT sessions, duration of ECT, and HRSD scores for pre-ECT period and after each ECT. But, it was observed that CGIS scores checked after each ECT decreased at a statistically significant level, while the number of patients who had reduced CGIS scores consecutively increased after each ECT.
ECT is a treatment method, which is preferable in the first place in depression patients and is known to be influential in the patients with resistance to treatment (16, 17) . Recent studies have reported that ECT is effective at high rates up to 80-90% for depressed patients for whom this method was preferred in the first place (16) . It has been also reported that the rate of response to ECT remained above 50% in the depression patients to whom one or more antidepressants were administered at sufficient doses and for sufficient durations without any response (18) .
Moreover, it was revealed that antidepressant impact of ECT usually arose earlier than that of antidepressants (17) .
In parallel with these findings, our study suggested that within the patient group consisting of those diagnosed with treatment-resistant depressive disorder, the percentage of patients whose HRSD scores decreased by 50% by the end of 2 nd week of ECT was 100%, whereas the percentage of the patients whose HRSD scores dropped below 7 was found to be 75%. In the literature, studies on the success of seizures during ECT usually blame the dose of the stimulus and the anesthetics for failed seizures (22) . They also discuss factors affecting the seizure threshold such as age, sex, and the position of the electrode (23) (24) (25) (26) . In a study, no relationship was observed between the diagnoses and the duration or success of the seizures (24) . In a systematic review, it was reported that seizure duration alone should not have served as a marker of the adequacy of treatment, since there were complex relations between stimulus dosing and seizure duration (25) . In early stages of ECT application the important point was considered to be ensuring seizure activity with a sufficient duration, and therefore the efficiency of ECT was associated with the length of seizure and stimulus dose above seizure threshold (1) . An effective seizure is regarded as the one, which takes about 25 seconds as a standard, and any shorter seizure activity is associated with negative clinical outcomes (26) . sessions of ECT to depression patients, and concluded that the length of seizure was a strong determinant of the clinical response to ECT. In our study, on the other hand, similar ECT durations were recorded in all patient groups, with no statistically significant difference. However, expected ECT durations were achieved in all of our patients.
Parameters affecting ECT duration were reported to include elderly age, being female, having ECT history, and number of ECT sessions (30) . In our study, average age was approximately 50, and significant difference was observed between the patient group with ECT history and without ECT history in terms of remission.
Limitations of our study are relatively small sample size, and lack of a healthy control group with no clinical to compare effectiveness of the ECT.
In line with the findings derived from our study and the existing literature, we can firmly speculate that ECT is still effective in depressive disorder patients with resistance to treatment, refusal to eat and drink and suicide ideation, and that it is a method of treatment affecting depression and clinical improvement levels. We can also underline that there was no difference among the patient groups that we applied ECT in terms of number and duration of ECT sessions, but in a way to ensure an acceptable balance, all of our patients completed sufficient number and duration of ECT sessions. However, the fact that the patients with ECT history had lower rate of remission as compared to the patients without ECT history made made is to consider the possibility that the disease may have crossed into chronic stage or former ECT sessions may have decreased the susceptibility to treatment.
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